GENB - Company ID 0002100782
As of 2026-07-10, Generate Biomedicines, Inc. (GENB) has a market capitalization of $2.02 B, making it the #2131 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-10 | $2.02 B |
| 2026-07-09 | $2.02 B |
| 2026-07-08 | $2.02 B |
| 2026-07-07 | $2.08 B |
| 2026-07-06 | $2.17 B |
| 2026-07-05 | $2.23 B |
| 2026-07-04 | $2.23 B |
| 2026-07-03 | $2.23 B |
| 2026-07-02 | $2.20 B |
| 2026-07-01 | $2.12 B |
| 2026-06-30 | $2.16 B |
| 2026-06-29 | $2.22 B |
As of 2026-07-10, Generate Biomedicines, Inc. (GENB) has a market capitalization of $2.02 B, making it the #2131 most valuable US-listed company.
Generate Biomedicines, Inc. is the #2131 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-28 | $2.11 B |
| 2026-06-27 | $2.11 B |
| 2026-06-26 | $2.10 B |
| 2026-06-25 | $2.11 B |
| 2026-06-24 | $2.08 B |
| 2026-06-23 | $1.98 B |
| 2026-06-22 | $2.02 B |
| 2026-06-21 | $1.86 B |
| 2026-06-20 | $1.86 B |
| 2026-06-19 | $1.86 B |
| 2026-06-18 | $1.82 B |
| 2026-06-17 | $1.78 B |
| 2026-06-16 | $1.70 B |
| 2026-06-15 | $1.74 B |
| 2026-06-14 | $1.59 B |
| 2026-06-13 | $1.59 B |
| 2026-06-12 | $1.62 B |
| 2026-06-11 | $1.67 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.